Clinical Trials Browser

Pancreatic Neoplasms

Biliary Tract Neoplasms, Gallbladder Neoplasms, Recurrence

Gastroesophageal Adenocarcinoma

Cholangiocarcinoma

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Carcinoma, Hepatocellular, Cholangiocarcinoma

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Adenocarcinoma, Carcinoma, Esophageal Neoplasms, Stomach Neoplasms

Carcinoma, Hepatocellular

Biliary Tract Neoplasms

Fibrolamellar hepatocellular carcinoma, Carcinoma

Carcinoma, Hepatocellular

Advanced Biliary Tract Cancer

Carcinoma, Hepatocellular, Liver Neoplasms

Adenocarcinoma, Stomach Neoplasms

Biliary Tract Neoplasms

Advanced Biliary Tract Carcinoma

Carcinoma, Hepatocellular, Liver Cirrhosis

Carcinoma, Hepatocellular

Hepatobiliary Cancers

Carcinoma, Hepatocellular

Biliary Tract Neoplasms, Carcinoma, Hepatocellular

Biliary Tract Neoplasms, Cholangiocarcinoma

Carcinoma, Hepatocellular

Cholangiocarcinoma

Unresectable Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Cholangiocarcinoma

Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Triple Negative Breast Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular, Liver Neoplasms

Carcinoma, Hepatocellular

Cholangiocarcinoma

Esophageal Neoplasms

Biliary Tract Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Biliary Tract Neoplasms, Gallbladder Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Bile Duct Neoplasms, Cholangiocarcinoma

Pancreatic Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Biliary Tract Neoplasms

Gastric Adenocarcinoma

Colorectal Neoplasms, Endometrial Neoplasms

Cholangiocarcinoma

Biliary Tract Neoplasms

Adenocarcinoma Of Esophagus

Clinical Trials

Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer

AB02

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement

HAIC-quad

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

DG-03

Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC

DESTINY-BTC01

DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

ALICE

A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)

A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma

Ph2 Study of Savolitinib and Durvalumab (MEDI4736) Combination in Advanced MET Amplified Gastric Cancer(VIKTORY-2)

CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers

TACTIC

Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis

TREMENDOUS-2

LIVER-R

SLIDE-HCC

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer

Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma

Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma

REFINE-IO

ZENOBIA

Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Proton-STRIDE

SIRT With Tremelimumab and Durvalumab for Resectable HCC

LIVIGNO-2

Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)

PALEO

Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)

Photon-STRIDE

Safety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular Carcinoma

RUGB

DUMELEP

Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

DURIPANC

Cryoablation and Arterial Infusion of SD-101 in Combination with Durvalumab and Tremelimumab

TREMENDOUS

OPTIMUM

Phase 2 Study of Trastuzumab Deruxtecan in the Neoadjuvant Treatment, or Trastuzumab Deruxtecan Plus Capecitabine Plus Durvalumab(MEDI4736) in the Preoperative and Postoperative Adjuvant Treatment for Patients with HER2 Positive Gastric and Gastroesophageal Junction Adenocarcinoma

SERPENTINE

Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma

A Study of Tumor-Treating Fields in Combination With Durvalumab and Gemcitabine/Cisplatin in Biliary Tract Cancers

Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery